HR+/HER2-negative Breast Cancer Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
Endometrial CancerSquamous Cell Carcinoma of Head and NeckBladder Cancer+1 more
Totus Medicines241 enrolled18 locationsNCT05683418
Recruiting
Phase 1Phase 2
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Metastatic Breast CancerHR+/HER2-negative Breast Cancer
SynDevRx, Inc.52 enrolled10 locationsNCT05455619